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Myeloid cells make a pivotal contribution to tissue homeostasis during inﬂammation. Both tissue-speciﬁc
resident populations and inﬁltrating myeloid cells can cause tissue injury through aberrant activation
and/or dysregulated activity. Reliable identiﬁcation and quantiﬁcation of myeloid cells within diseased
tissues is important to understand pathological inﬂammatory processes. Flow cytometry is a valuable
technique for leukocyte analysis, but a standardized ﬂow cytometric method for myeloid cell populations
in the eye is lacking. Here, we validate a reproducible ﬂow cytometry gating approach to characterize
myeloid cells in several commonly used models of ocular inﬂammation. We proﬁle and quantify myeloid
subsets across these models, and highlight the value of this strategy in identifying phenotypic differences
using Ccr2-deﬁcient mice. This method will aid standardization in the ﬁeld and facilitate future in-
vestigations into the roles of myeloid cells during ocular inﬂammation.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Myeloid cells and their contribution to tissue homeostasis and
inﬂammation represent a key area in human immunological dis-
ease. Myeloid cells have been historically divided into resident and
inﬁltrating populations. Depending on the inﬂammatory stimuli,
each of these populations can exhibit a wide range of actions and
roles such as driving acute inﬂammatory responses and both
initiating and regulating lymphocyte-driven adaptive responses
(Gordon et al., 2014; Janeway and Medzhitov, 2002). Resident
myeloid cells continuously sample the tissue micro-environmental autoimmune uveitis; FACS,
duced uveitis; CNV, Choroidal
CR2, C-C chemokine receptor
lmology, 11-43 Bath Street,
ch and Early Development,
Innovation Center Basel, F.
Basel, Switzerland.
r Ltd. This is an open access articleacting to trigger inﬂammatory responses to pathogens and tissue
trauma and pave the way for the progressive recruitment of
circulating myeloid cells such as neutrophils and inﬂammatory
monocytes. Importantly, both resident and inﬁltratingmyeloid cells
can themselves cause tissue injury through their aberrant activa-
tion and/or excessive dysregulated activity (Murray and Wynn,
2011).
Progress in understanding myeloid cell biology has been aided
by technological advances in ﬂow cytometry that allow staining of
more than 17 individual antibody-ﬂuorophore combinations for
analysis (Perfetto et al., 2004), facilitating in-depth immunophe-
notyping of myeloid cells and their contribution to disease. Careful
validation of this powerful technique, across speciﬁc tissues and
cell types for the markers used, is critically important for reliable
interpretation and meaningful comparison. There is currently no
consensus regarding a standardized ﬂow cytometry panel for
myeloid cells, in part due to the lack of deﬁnitive myeloid cell
lineage markers (Hume, 2011). This has resulted in widespread
variation in the use of cell surface markers to deﬁne myeloid cell
populations (Murray et al., 2014).
The inconsistent identiﬁcation of myeloid cells hinders stan-
dardization in the ﬁeld, and deleteriously affects reproducibility,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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multi-color panels. Investigators of gene expression in the mouse
immune system recognized this problem and proposed a stan-
dardized approach to ﬂuorescence-activated cell sorting (FACS) of
single leukocyte sub-populations (Gautier et al., 2012). However,
these strategies are unsuitable for assessing multiple inﬁltrating
myeloid cell populations within a tissue. To this end, Rose et al.
proposed a novel gating strategy for analyzing the splenic myeloid
compartment (Rose et al., 2011).
The same considerations apply to characterization of myeloid
populations in the eye during inﬂammation. Traditionally involved
in leukocyte-driven inﬂammatory diseases, myeloid cells have now
been implicated in chronic progressive eye conditions such as age-
related macular degeneration (AMD) (Bainbridge, 2007; Luhmann
and Ali, 2011). Neutrophils mediate tissue damage through pro-
duction of reactive oxygen species (ROS) and inﬂammatory
monocytes contribute both to disease progression and regulation of
inﬂammation during models of uveitis (Kerr et al., 2008; London
et al., 2013). Additionally, pro-angiogenic factors produced in
response to macrophages contribute to angiogenesis during laser-
induced choroidal neovascularization in mice (Sakurai et al.,
2003). While CD11bþ myeloid cell subsets in these models have
been described using ﬂow cytometry, CD11b is not exclusively
myeloid-expressed, and resident CD11bþ microglia, dendritic cells
and perivascular macrophages are difﬁcult to differentiate as pop-
ulation phenotyping is inconsistent and unvalidated.
We apply the strategy reported by Rose et al. to describe a
detailed and validated approach to the analysis of myeloid cell
populations in the retina and retinal pigmented epithelium (RPE)-
choroid complex during inﬂammation. This strategy employs spe-
ciﬁc antibody clones targeting the cell surface proteins CD11b,
CD11c, Ly6G, Ly6C, NK1.1 in combination with the FSC and SSC
parameters and a live/dead cell discrimination dye. Whilst posi-
tivity for CD11c, Ly6G and NK1.1 discriminates dendritic cells,
neutrophils and NK cells respectively, circulating monocytes can be
characterized into two populations using cell surface expression of
Ly6C. Ly6Cþ cells are rapidly recruited to sites of inﬂammation and
Ly6Cneg cells patrol blood vessels and in the tissue comprise resi-
dent microglia (Auffray et al., 2009).
Using Ccr2/ knockout mice that exhibit impaired recruitment
of myeloid cells to sites of inﬂammation (Newson et al., 2014), we
show that this strategy can reveal phenotypic differences between
myeloid populations in laser-induced CNV. We highlight and
address speciﬁc issues of this gating strategy with regards to its
application to ocular tissue to provide an additional resource for the
investigation of ocular biology.
2. Materials and supplies
2.1. Animals
All in vivo procedures were conducted under the regulation of
the UK Home Ofﬁce Animals (Scientiﬁc Procedures) Act 1986, and
the study was in compliance with the ARVO Statement for the Use
of Animals in Ophthalmology and Vision Research. C57BL/6J and
CCR2/ (C57BL/6J background) mice were used in this study. All
mice used in this study were 6e10 weeks old at the time of
procedure.
2.2. Buffers
Flow buffer consisted of PBS with 2 mM EDTA and 0.1% (w/v)
bovine serum albumin (all Sigma-Aldrich Ltd., UK). Sorting buffer
comprised DMEM, 2% (v/v) fetal calf serum, 10 mM HEPES (all
Invitrogen; Life Technologies Limited, UK).3. Detailed methods
3.1. Induction of experimental autoimmune uveoretinitis (EAU)
For the induction of EAU in C57BL/6J mice, human RBP 1e20
peptide (H-Gly-Pro-Thr-His-Leu-Phe-Gln-Pro-Ser-Leu-Val-Leu-
Asp-Met-Ala-Lys-Val-Leu-Leu-Asp-OH, 10 mg/ml; Insight Biotech-
nology, UK) was mixed with an equal volume of Complete Freund's
Adjuvant (Sigma Aldrich, UK) supplemented with 1.5 mg/ml of
Mycobacterium tuberculosis H37R (DIFCO Laboratories, UK) to
create an emulsion. 50 ml was subcutaneously injected into each
ﬂank to give a total dose of 500 mg per mouse. 1.5 mg of Pertussis
toxin (Tocris Bioscience, UK) was then administered intraperito-
neally (Cortes et al., 2008).
3.2. Induction of endotoxin-induced uveitis (EIU)
EIU was induced by intravitreal administration of 1 ng of lipo-
polysaccharide (Sigma Aldrich, UK) into each eye using a micro-
surgical syringe and 38 gauge needle (Hamilton, Switzerland)
(Trittibach et al., 2008).
3.3. Laser-induced choroidal neovascularization
The fundus was visualized by coupling a microscope coverslip
(VWR International Ltd., UK) to the ocular surface using a viscous
topical ocular lubricant (Viscotears; Novartis, UK). Choroidal neo-
vascularization was induced by rupturing Bruch's membrane using
a slit-lamp-mounted diode (680 nm) laser system (Keeler, UK) with
the following settings: 210 mW power; 100 ms duration; 100 mm
spot diameter. These settings consistently generate a subretinal gas
bubble indicative of successful rupture of Bruch's membrane and
consequent induction of choroidal neovascularization (Balaggan
et al., 2006). Ten burns were delivered to ensure sufﬁcient cell
numbers for ﬂow cytometric analysis and FACS.
3.4. Preparation of cell suspension
Eyes were dissected microsurgically in 1 ml ice-cold RPMI 1640
(Invitrogen; Life Technologies Limited, UK) to isolate the retina
(excluding the ciliary marginal zone) and RPE-choroid complex. For
laser-induced CNV, the retinas and RPE-choroid complexes of both
eyes were pooled for each animal before undergoing enzymatic
digestion with a solution containing 25 mg/ml DNAse (Sigma-
Aldrich Limited, UK) and 10 mg/ml Collagenase D (Roche Di-
agnostics, UK) for 30 min at 37 C. The digested material was
homogenised by gentle trituration with a pipette, before being
ﬁltered. For EIU and EAU, the dissected retinawas transferred into a
1.5 ml reaction tube and mechanically dissociated by rapping the
tube across a reaction tube rack ten times, before being ﬁltered.
Filtrationwas accomplished by passing the sample through a 60 mm
mesh ﬁlter plate (Millipore UK Ltd., UK) by centrifugation (300 g for
5 min). The supernatant was discarded and the sample resus-
pended with either ﬂow or sorting buffer.
Splenic samples were prepared by homogenising the tissue
between two frosted polysine slides (VWR International Ltd., UK) in
1 ml ice-cold phosphate buffered saline (PBS; Sigma-Aldrich
Limited, UK). Samples were centrifuged (300 g for 5 min) and the
cell pellet underwent red blood cell lysis using 1 ml ACK buffer
(Invitrogen; Life Technologies Limited, UK) for 20 s. Lysis was
terminated by adding 50 ml PBS to the sample, and the sample was
ﬁlteredwith a 70 mm cell strainer (BD Labware, UK) and centrifuged
(300 g for 5 min). The resultant cell pellet was resuspended with
either ﬂow or sorting buffer.
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The cell ﬁltratewas suspended in ice-cold ﬂow buffer to produce
a single cell suspension and blocked with rat anti-mouse CD16/32
clone 2.4G2 Fc block (5 ng/ul; BD Biosciences, UK) for 10min at 4 C.
Surface staining was performed in the dark for 20 min at 4 C in
ﬂow buffer. Cells were washed between each incubation with ﬂow
buffer. Intracellular staining was performed after ﬁxation and
permeabilization (BD Cytoﬁx/Cytoperm; BD, UK).
A list of titrated surface markers for these experiments includes:
CD4 clone GK1.5 PE (2 ng/ul; BioLegend., UK); CD8a 53e6.7 PE (2
ng/ul; eBioscience Ltd., UK); CD8 clone 53e6.7 APC (2 ng/ul; BD
Biosciences, UK); B220 RA3-6B2 PE (2 ng/ul; eBioscience Ltd., UK);
CD11b clone M1/70 PE-Cy7 (2 ng/ul; eBioscience Ltd., UK); CD11b
clone M1/70 BV711 (0.5 mg/ml; Biolegend Ltd., UK), CD11c clone
N418 FITC (1.25 ng/ul; eBioscience Ltd., UK); Ly6G clone 1A8 APC (2
ng/ul; eBioscience Ltd., UK); Ly6G clone 1A8 BV421 (1.25 ng/ul;
Biolegend Ltd., UK); NK1.1 clone PK136 PerCP/Cy5.5 (2.5 ng/ul;
Biolegend, Ltd., UK); NK1.1 clone PK136 APC (2 ng/ul; eBioscience
Ltd., UK); Ly6C clone HK1.4 BV510 (0.63 ng/ul; Biolegend, Ltd., UK);
F4/80 clone CI:A3-1 RPE (AbD Serotec, UK); live-dead discrimina-
tion with SYTOX Blue (2.5 mM/ml; Invitrogen; Life Technologies
Limited, UK) or DRAQ7 (1.5 mM/ml; Biostatus Ltd., UK). Intracellular
staining for IBA-1 was performed using an antibody obtained by
conjugating a rabbit anti-Iba-1 antibody (Wako GmbH, Germany)
with AlexaFluor 647 (Molecular Probes antibody labelling kit; Life
Technologies Limited, UK).
3.6. Data acquisition and ﬂuorescence-activated cell sorting (FACS)
Fluorescence-minus-one controls were used for gating analyses
to distinguish positively from negatively staining cell populations.
Compensation was performed using single color controls prepared
from BD Comp Beads (BD Biosciences, UK) for cell surface staining
or dead splenocytes (heated at 65 C for 1 min) for live-dead
discrimination. Flow cytometric analysis was carried out with a
Fortessa X-20 (BD Biosciences, USA) equipped with 355 nm,
405 nm, 488 nm, 561 nm and 640 nm excitation lasers. All samples
were run at 6 ml/minute (low setting) and data analysis was per-
formedwith FlowJo v.10.0.7 (FlowJo LLC, USA). FACS was performed
using an Inﬂux (BD Biosciences, USA) equipped with 355 nm,
405 nm, 488 nm, 561 nm and 640 nm excitation lasers. All data
collection and sorting were performed using BD FACS Diva software
(BD Biosciences, UK). Cells were sorted into DMEM media con-
taining 50% FCS (Invitrogen; Life Technologies Limited, UK) using
50 psi and a 70 mm nozzle.
Absolute cell numbers were obtained by using a standard curve
constructed using serial dilutions of 5  104 Accucount blank par-
ticles (Spherotech, Germany) in a set volume of 300 ml; each dilu-
tion was run at 6 ml/min for 3 min. Before acquisition, retinal and
RPE-choroidal samples were resuspended in 300 ml and run at 6 ml/
min for 3 min. The identical volumes and acquisition rates allowed
interpolation of absolute cell numbers using Graphpad Prism v6
(Graphpad Software Inc., USA).
3.7. Cytospin preparation and staining
For cytologic analysis of cell preparations, cells were mounted
on slides using a Cytospin centrifuge (ThermoElectron, UK) for
5 min at 1000 RPM. Cells were air-dried, then ﬁxed and stained
using a Romanowsky stain (Shandon Kwik-Diff; (Fisher Scientiﬁc,
UK)) according to manufacturer's instructions. Cytospin prepara-
tions were imaged using a standard light microscope using a 40
(Diaplan; Leitz, Germany). Independent analysis of the slides was
performed by an accredited cytologist masked to the study whoassessed homogeneity of the cytopsin preparation over 20 ﬁelds of
view.
3.8. Immunohistochemistry
Retinal ﬂat mounts were prepared as described before
(Luhmann et al., 2012). Brieﬂy, eyes were removed and ﬁxed at
room temperature for 5 min in 4% buffered paraformaldehyde
(PFA); retinas were dissected and post-ﬁxed at room temperature
in 4% PFA 10 min. Tissue samples were washed twice with PBS,
blocked in blocking solution (1% (w/v) BSA (Sigma Aldrich, UK), 5%
(v/v) nonspeciﬁc goat serum (AbD Serotec, UK), 1% (v/v) Triton X-
100 (Sigma Aldrich, UK)) for 1 h at room temperature. Samples
were incubated over-night at 4 C with the following primary an-
tibodies, diluted in blocking solution: rabbit anti-Iba1 clone
019e19741 (1:500, Wako GmbH, Germany), rat anti-Ly6C clone
HK1.4 (1:200, Abcam, UK). The next day, after washing 3  10 min
with blocking solution, ﬂat-mounts were incubated for 2 h at room
temperature with AlexaFluor 488-conjugated anti-rabbit IgG and
AlexaFluor 546-conjugated anti-rat IgG secondary antibodies
(1:500; Molecular Probes; Life Technologies Ltd., UK) in blocking
buffer. Samples were washed 3  10 min with blocking buffer,
1 10minwith PBS andmounted on a glass slidewith ﬂuorescence
mounting medium (Dako Fluorescence Mounting Medium; Dako,
UK). Flat-mount tissue was examined by confocal laser scanning
microscopy (Leica DM5500Q; Leica Microsystems, Germany), using
a 40 objective. High-resolution z-stack images (0.5 mm thickness)
of regions of interest were acquired and z-projected to generate the
images presented.
3.9. Statistical analysis
Data were plotted and analysed for statistical signiﬁcance in
Graphpad Prism v6 (Graphpad Software Inc., USA) using the non-
parametric Mann Whitney (two-tailed) method. P-values of
0.05 were considered signiﬁcant.
3.10. Gating strategy is reproducible in the splenic myeloid
compartment
We reproduced and cytologically validated the gating strategy
published by Rose et al. using different antibody-ﬂuorophore
combinations (Rose et al., 2011). Following exclusion of debris
and cellular aggregates, a live/dead discrimination was performed.
Plotting CD11b against CD11c allowed dendritic cells
(CD11chighCD11bþ) to be differentiated from other CD11bþmyeloid
subsets. The latter cell population was then analysed by plotting
NK1.1 against Ly6G. NK1.1 is a marker for natural killer cells which
are thought to be lymphoid cells deriving predominantly from
lymphoid progenitors (Vivier et al., 2008; Yu et al., 2013) but can
constitute a large proportion of CD11bþ cells.
The myeloid gating strategy allowed natural killer cells
(CD11bþNK1.1þ) and neutrophils (CD11bþLy6Gþ) to be distin-
guished from the remaining monocytes and macrophages
(CD11bþNK1.1negLy6Gneg). These monocytes and macrophages can
be classiﬁed into inﬂammatory (Ly6Chigh) and non-inﬂammatory or
resident (Ly6Clow/neg) based on the expression of the Ly6C antigen
(Geissmann et al., 2010). FACS using this panel and strategy allowed
each myeloid cell population to be isolated. Cells were identiﬁed
using cytological characteristics based on nuclear morphology,
nuclear/cytoplasmic ratio, cytoplasmic staining and granularity.
Following ﬁxation and Romanowsky staining, masked analysis by
an accredited cytologist conﬁrmed that the gating strategy isolated
the intended myeloid cell populations in the spleen (Fig. 1).
Fig. 1. Identiﬁcation and cytology validation of myeloid leukocytes in the mouse spleen using an established ﬂow cytometry gating strategy. The ﬂow cytometry gating
strategy shows sequential exclusion of debris, doublets and dead cells from total C57BL/6 mouse splenocytes. Lymphocytes were excluded in a dump gate using CD4, CD8 and B220
in the same channel (gate A). CD11bþCD11chigh dendritic cells were then gated (gate B) followed by exclusion of NK1.1þ natural killer cells (gate C) and Ly6Gþ neutrophils (gate D)
The remaining cells were classiﬁed into eosinophils (gate E), resident (gate F) and inﬂammatory monocyte/macrophage populations (gate G) using side scatter (SSC) and Ly6C.
Cytospin preparations from FACS sorted populations were prepared and stained with Romanowsky stain variant. These are shown with the corresponding ﬂow cytometry gates
(AeG) and cytology description. NK cells (gate C) have been excluded from cytological analysis as they are not classiﬁed as myeloid cells; n ¼ 2 animals; 2 independent experiments.
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Once validated this gating strategy was applied to both naïve
retina and RPE-choroid of wild typemice (Fig. 2A,B). In both tissues,
there were low numbers of CD11bþmyeloid cells present (means of
2600 in the retina and 3800 in the RPE-choroid) (Fig. 2C,D).
CD11bþCD11chigh classical dendritic cells were rare in retina
compared to the RPE-choroid, consisting of 0.23% and 13.65% of the
CD11bþ myeloid cell population respectively. Both neutrophils and
inﬂammatory monocytes/macrophages were present in normal
RPE-choroid, comprising 7.54% and 28.48% of the native CD11bþ
myeloid population (Fig. 2D), with the remainder mainly composed
of resident monocytes/macrophages (45.18%) with very small NK
(4.30%) and eosinophil (0.84%) populations present. In normal
retina, the lack of other inﬂammatory subsets, such as neutrophils
and inﬂammatory monocytes/macrophages, was consistent with
the absence of inﬂammatory stimuli in an immune privileged
setting. Here, 98.71% of the CD11bþ myeloid cells present were
resident monocytes/macrophages (CD11bþNK1.1negLy6GnegLy6-
Clow/neg) (Fig. 2C).
3.12. Retinal microglia identiﬁed as resident monocyte/macrophage
population
In order to better understand the inﬂammatory processes
involved, any gating strategy for models of ocular inﬂammation
must accurately identify resident CD11bþ cells of which three
populations are currently known, microglia, dendritic cells (DC)and perivascular macrophages (Chen and Xu, 2015). Studies with
transgenic reporter mice have shown that the greatest in number of
the three populations are retinal microglia (Kezic et al., 2008;
London et al., 2013) and they serve to maintain tissue homeosta-
sis (Dick, 2003). Lineage studies have shown that these tissue-
resident macrophages are derived from the yolk sac, independent
from haematopoiesis (Schulz et al., 2012). Parabiosis experiments
have shown that these specialized cells self-maintain, remaining
independent of contributions from circulating monocytes (Ajami
et al., 2011; Hashimoto et al., 2013).
Microglia and DCs are CD11bþCD45low and can be distinguished
in steady state by DC expression of CD11c. The classical immuno-
histochemical marker for CNS microglia is the intracellular ionized
calcium binding adapter molecule 1 (Iba-1), although it should be
noted that Iba-1 is not myeloid-speciﬁc outside of the brain and
retina (Imai et al., 1996). Staining for Iba-1 requires ﬁxation and
permeabilization and the morphological changes (from highly
branched and ramiﬁed to ameboid) of microglia associated with
their activation cannot be distinguished by ﬂow cytometry or
cytospin. Other groups have used the CD11bþCD45low surface
marker phenotype to deﬁne microglia as the dominant resident
myeloid population in the retina (Kettenmann et al., 2011; Zhang
et al., 2002). Perivascular macrophages, another resident myeloid
population, expresses high levels of CD45, necessitating careful
discrimination between low and high expression of CD45
(depending upon ﬂourochrome choice and staining conditions)
(Patel et al., 2013). The identiﬁcation of microglia by the CD45low
phenotype is compounded by results in models of CNS disease that
Fig. 2. Application of the myeloid gating strategy in the naïve mouse eye. Analysis of the retinal (A) and RPE-choroidal (B) compartment with the gating strategy, representing
the acquisition of single cell suspensions from either pooled retina or RPE-choroid from 1 animal. Absolute cell numbers and percentages of myeloid subsets present in the retina (C)
and RPE-choroid (D) are shown. Gates are as follows: A e lymphocytes; B e dendritic cells; C e natural killer cells; D e neutrophils; E e eosinophils; F e resident monocyte/
macrophages; G e inﬂammatory monocyte/macrophages; n ¼ 4 animals (pooled eyes); mean ± SD shown; 2 independent experiments.
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(Ponomarev et al., 2005).
We sought to examine the outlined gating strategy in steady
state conditions and so analysed the retina and RPE-choroid from
naïve mice (Fig. 2A and B). Resident monocytes/macrophages
(CD11bþNK1.1negLy6GnegLy6Clow/neg) formed the majority of
CD11bþmyeloid cells in the normal wild type retina (Fig. 2C). In the
RPE-choroid complex resident monocytes/macrophages were the
dominant population although we could detect low cell counts
from all other myeloid subtypes identiﬁed using the gatingstrategy. This tissue is highly vascularized and the presence of these
other subsets in steady state could represent the detection of
circulating myeloid cells normally present in systemic circulation.
To further conﬁrm our assumption that the resident monocyte/
macrophage population in this gating strategy corresponds to
retinal microglia in steady state, we analysed the retinal microglia
(CD11bþCD45low) subset in naïve retina for Iba-1- and Ly6C-
positivity (Fig. 3A). These data revealed that, consistent with pre-
vious studies, the majority of the CD11bþCD45low cell population
was Iba-1þ retinal microglia cells (Fig. 3B). The preponderance of
Fig. 3. Conﬁrmation of the resident monocyte/macrophage population identiﬁed in the naïve retina as retinal microglia. (A) The myeloid cell population in naïve retina was
deﬁned by the CD11bþCD45low immunophenotype. (B) 99% of this CD11bþCD45low populationwas positive for the intracellular microglia marker IBA-1. (C) The majority (97%) of the
CD11bþCD45low population is Ly6Clow/neg. (D) Confocal microscopy of retinal ﬂatmount showing IBA-1 (red) and Ly6C (green) staining. A composite image reveals no co-localization
between IBA-1 and Ly6C suggesting that the majority of the Ly6C stain in this immunohistochemistry originates from endothelial cells; n ¼ 3 animals (individual eyes); 3 inde-
pendent experiments.
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CD11bþLy6Clow/neg subset in the gating strategy was composed
mainly of retinal microglia (Fig. 3C). FACS sorting of
CD11bþCD45lowIba-1þ and CD11bþLy6Clow/neg populations from
naïve retina revealed that the masked cytological analysis of the
individual populations showed no difference between the nuclear
morphology of these populations (Fig. 3B, C); assessment of cyto-
plasmic features was not possible as the permeabilization step
necessary for intracellular Iba-1 staining caused cytoplasmic
rupture and loss in subsequent processing.
As a further means of validation, immunohistochemistry was
performed using Iba-1 and Ly6C on retinal ﬂatmounts of naïve eyes
(Fig. 3D). The majority of Ly6C expression was derived from
endothelial cells (Jutila et al., 1988). Confocal microscopy high-
lighted the absence of co-localization between Iba-1 and Ly6C,providing immunohistochemical conﬁrmation that Iba-1þ cells
have a Ly6Clow/neg phenotype.
3.13. Using the Rose et al. ﬂow cytometry gating strategy in
different ocular inﬂammatory models
Following the validation of the Rose et al. ﬂow cytometry gating
strategy on naïve ocular tissue we applied it to three mouse models
of intraocular inﬂammation: experimental autoimmune uveitis
(EAU), endotoxin-induced uveitis (EIU), and laser-induced
choroidal neovascularization (CNV), for evaluation of differential
immune phenotyping.
EAU is an antigen-speciﬁc T cell-driven model of human pan-
uveitis comprising inﬁltration of T cells and multiple myeloid cell
populations (Gardner et al., 2015). EIU is a sterile LPS-driven
Fig. 4. The myeloid gating strategy distinguishes resident from inﬁltrating cells in mouse models of ocular inﬂammation. Flow cytometry plots show the myeloid gating
strategy as applied to dissected mouse eyes following induction of three different ocular inﬂammatory models, experimental autoimmune uveitis (EAU), endotoxin induced uveitis
(EIU) and laser induced choroidal neovascularization (CNV). Cytospin preparations from FACS sorted populations (indicated by gate and color) during ocular inﬂammation are
shown above the relevant plots. EAU and EIU plots are representative of data from individual eyes, while eyes were pooled per animal for CNV. Gates are as follows: A e lym-
phocytes; B e dendritic cells; C e natural killer cells; D e neutrophils; E e eosinophils; F e resident monocyte/macrophages; G e inﬂammatory monocyte/macrophages. Cytology
from dendritic cells (gate B), neutrophils (gate D), resident monocyte/macrophages (gate F) and inﬂammatory monocyte/macrophages (gate G) are shown; n ¼ 12 animals (pooled
eyes); 2 independent experiments.
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eye mirroring aspects of human anterior uveitis (Trittibach et al.,
2008). Retinal tissues were harvested at 18 h and 26 days post in-
duction for EIU and EAU respectively, corresponding to peak levels
of leukocyte inﬁltration (Chu et al., 2013; Trittibach et al., 2008). As
the Bruchs membrane stays intact during EIU and EAU, the choroid
is not typically analyzed in these models. Laser-induced CNV rep-
resents an acute tissue inﬂammation model that results in neo-
vascularization, sharing similarities with wet age-related macular
degeneration. Myeloid inﬁltration peaks 2e3 days post laser in-
duction (Sakurai et al., 2003; Tsutsumi et al., 2003) and analysis of
the inﬁltrate in retina and RPE-choroid was performed at day 3.
The ﬂow cytometry gating strategy was reproducible in all three
models with retina, and with RPE-choroid in laser-induced CNV
(Fig. 4).
Masked cytological analysis of ﬁxed and stained FACS-isolated
populations conﬁrmed that the cell populations corresponded to
the splenic isolates and known cytological characteristics.
The data acquired using the gating strategy enabled us to
compare peak disease across the different models both qualita-
tively and quantitatively. At peak disease in all models we observed
elevated absolute counts of total CD11bþ myeloid cells (Fig. 5).
This is due to greater inﬁltrating numbers of classical dendritic
cells (CD11bþCD11chigh), inﬂammatory monocyte/macrophages(CD11bþNK1.1negLy6GnegLy6Chigh) and non-myeloid natural killer
cells (CD11bþNK1.1þ) into the eye. In EIU, the myeloid inﬁltrate into
the retinawas composed ofmainly neutrophils (CD11bþLy6Gþ) and
inﬂammatory monocytes (CD11bþLy6Cþ). Neutrophils were also
detected in the retina and RPE-choroid at peak disease of laser-
induced CNV and very low numbers were observed inﬁltrating
the retina at peak EAU disease (Fig. 5). This low number of inﬁl-
trating neutrophils during peak EAU observed in C57BL/6mice here
reﬂects the mouse genetic background as neutrophils can form a
signiﬁcant component of the inﬂammatory inﬁltrate during EAU
when induced in B10.RIII mice (Gardner et al., 2015).
Using the ﬂow cytometric gating strategy described above,
tissue-resident retinal microglia in the eye were characterized
reproducibly as the CD11bþNK1.1negLy6GnegLy6Clow/neg population,
which stays relatively constant at day 3 post laser-induced CNV (in
both retina and RPE-choroid) (Fig. 5). In contrast, we observed a
reduction in EIU and a 5 fold increase (from a mean of 2500 to
12,600) in the absolute number of the CD11bþNK1.1negLy6Gne-
gLy6Clow/neg cell population of that observed in naïve mice at peak
disease EAU (Fig. 5). It is unclear whether this elevation represents
the differentiation of inﬁltrating Ly6Chigh inﬂammatory monocytes
into Ly6Clow/neg macrophages or the proliferation of resident
microglia; however, this increase in this population is consistent
with an increase in CX3CR1þ (patrolling monocytes and resident
Fig. 5. Quantiﬁcation of myeloid populations in the eye during mouse models of ocular inﬂammation. Charts show the quantiﬁcation of the absolute cell counts and per-
centages of gated subsets of the total CD11bþ population in the various models at peak disease; n ¼ 6 animals (pooled eyes for CNV and EAU, individual eyes for EIU); mean ± SD
shown; 2 independent experiments; colors in individual bars match individual population gate from Figs. 1 and 4. Although not myeloid cells, CD11bþ NK cells are included as they
constitute a signiﬁcant proportion in EAU and CNV.
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et al., 2013).
3.14. Application and validation of the ﬂow cytometry gating
strategy in laser-induced CNV in CCR2/ animals
Differential expression of the C-C chemokine receptor 2 (CCR2)
has been shown between two functional subsets of murine bloodmonocytes. The so-called ‘inﬂammatory’ CCR2þCX3CR1lowGr1
(Ly6C/G)þ subset are actively recruited into inﬂamed tissues while
the ‘patrolling’ CCR2CX3CR1highGr1(Ly6C/G)neg subset is recruited
to non-inﬂamed tissues (Geissmann et al., 2003). Signaling through
CCR2 facilitates bonemarrow egress of myeloid cells and transgenic
targeted deletion of CCR2 in mice results in deﬁcient inﬁltration of
myeloid cells and an attenuation in the size of lesions following
laser-induced CNV (Tsutsumi et al., 2003).
Fig. 6. The myeloid gating strategy conﬁrms diminished inﬂammatory monocyte
inﬁltration in CCR2 deﬁcient mice during CNV. Quantitation of absolute numbers of
myeloid cells present in day 3 RPE-choroid, post laser-induction of CNV in Ccr2/
animals and wild type (WT) controls; n ¼ 6 animals (pooled eyes) per group,
mean ± SD; * ¼ P  0.05 Mann-Whitney (two-tailed); 2 independent experiments;
colors in individual bars match individual population gate from Figs. 1 and 4. Although
not myeloid cells, CD11bþ NK cells are included as they constitute a signiﬁcant
proportion.
S.E. Liyanage et al. / Experimental Eye Research 151 (2016) 160e170168To validate the use of the ﬂow cytometry gating strategy under
inﬂammatory conditions and to characterize the reduced popula-
tion of inﬁltrating myeloid cells we replicated laser-induced CNV in
Ccr2/ and wild type controls. Analysis at 3 days post-laser in-
duction revealed a signiﬁcant reduction in the absolute cell
numbers of the inﬂammatory monocyte/macrophage
(CD11bþNK1.1negLy6GnegLy6Chigh) subset in the RPE-choroid of
Ccr2/ animals as compared to wild type controls (Fig. 6). This is
consistent with the decrease in the circulating Ly6Chigh monocytes
seen in Ccr2/ animals (Serbina and Pamer, 2006). Therewas also a
signiﬁcant decrease in the CD11bþNK1.1negLy6GnegLy6Clow-neg
monocyte/macrophage population in Ccr2/ RPE-choroid (Fig. 6).
A similar reduction has been documented in circulating Ly6Clow
blood monocytes in Ccr2/ mice, raising the possibility that this
CD11bþNK1.1negLy6GnegLy6Clow-neg population is affected by the
Ccr2/ phenotype, by either recruitment or maturation from
Ly6Chigh monocytes (Gutierrez et al., 2011).4. Potential pitfalls and troubleshooting
4.1. Resolving myeloid populations in the ocular compartments
Flow cytometric analysis of the ocular compartments is chal-
lenging as myeloid cells represent a very small proportion of the
retina in steady state. Under inﬂammatory conditions and leuko-
cyte inﬁltration the myeloid cell proportion of total retinal cells
increases but, as we show in laser-induced CNV, can remain very
small. The other non-myeloid cells of the retina represent ‘back-
ground noise’ when analyzing myeloid cell populations. Subtle
adjustment to increase the forward scatter (FSC; measurement of
relative size) detector sensitivity (voltage) can help to improve the
resolution of myeloid cells from the differently sized retinal and
RPE-choroidal cells, however this may depend on the quality of
cellular preparation.
Poor retinal dissociation can result in cellular debris that can
impair resolution of myeloid cells. In this case increasing in the FSC
threshold may aid in cellular identiﬁcation; events with a FSC
below the threshold become undetectable (generally electronic
noise and cellular debris), enabling improved identiﬁcation of
whole cells. When increasing the FSC threshold, careful monitoring
of the CD11bþ population percentage will ensure that these cells donot fall below the threshold. Addition of an anti-CD45 antibody to
the panel may improve resolution of the myeloid cells by excluding
the CD45neg non-leukocytes as part of the gating strategy.
When identifying subsets, it is important to use ﬂuorescence-
minus controls for each individual experiment to deﬁne positive
populations. The use of isotype controls has well-described limi-
tations which include variability in staining and failing to account
for ﬂuorescence spillover. Due to the multicolor nature of this
strategy, we used ﬂuorescence-minus-one controls as for gating,
which are currently accepted as the gold standard in ﬂow cytom-
etry (Maecker and Trotter, 2006).
Distinguishing retinal microglia from macrophages is difﬁcult
due to several shared antigens, particularly when activated
(Guillemin, 2003). Recently, the retinal microglia from Cx3Cr1-re-
porter mice have been characterized using ﬂow cytometry. In
keeping with the strategy described here, retinal microglia were
identiﬁed as CD11bþCD11clowLy6GnegLy6Cneg (O'Koren et al., 2016).
4.2. Autoﬂuorescence
Cellular auto ﬂuorescence poses a potential issue as both retinal
and RPE-choroidal tissues have higher intrinsic cellular auto ﬂuo-
rescence than other peripheral tissues (Krause et al., 2014). In laser-
induced CNV, this is compounded by higher numbers of dead auto
ﬂuorescent cells from tissue damage resulting from laser injury.
The use of a live/dead dye allows removal of dead cells from sub-
sequent analysis. Care should be taken when choosing antibody-
ﬂuorophore combinations, by avoiding identiﬁcation of rare pop-
ulations or low expressed antigens using detectors (PMTs) where
auto ﬂuorescence can reduce resolution sensitivity of speciﬁc
cellular populations, such as the 530/30 detector excited by the
488 nm laser.
4.3. F4/80 macrophage marker and the inability to further
subdivide the monocyte/macrophage subset
The F4/80 antigen is commonly used as a marker for macro-
phages. In their report, Rose et al. omitted the use of an F4/80
antibody in the splenic myeloid compartment as they found that
individual F4/80 antibody clones differed in their ability to stain
macrophage populations. Moreover, the F4/80 antigen appeared
dispensable in deﬁning myeloid subsets in the mouse spleen (Rose
et al., 2011). Owing to its redundancy in this gating strategy (Fig. 7),
we chose not to incorporate F4/80 into the analysis of myeloid cells
in the ocular compartments.
In the spleen, CD11bþF4/80neg and CD11bþF4/80þ populations
were analysed for CX3CR1 (‘patrolling’ monocyte and resident
macrophages) expression (Geissmann et al., 2003). CX3CR1
expression was found to be higher in the CD11bþF4/80þ fraction in
comparison to the CD11bþF4/80neg compartment. However, no
differences in expression of CD115 (blood monocyte) and MHCII
(antigen presentation) surface markers were noted between these
populations (Breslin et al., 2013; Rose et al., 2011). This raises
concerns regarding the level of discrimination between monocytes
and macrophages provided by F4/80.
Despite these issues with F4/80, we recognize that both F4/80
and MHC class II have been used to deﬁne both macrophages and
retinal microglia. As such, individual researchersmay choose to add
these markers to this strategy as a means of comparing results from
this gating system to those previously used.
4.4. Discussion
To date, a standardized ﬂow cytometric analysis to characterize
ocular myeloid cell populations has been lacking. Using a gating
Fig. 7. F4/80 is redundant in deﬁning ‘inﬂammatory’ Ly6Chigh and ‘resident’ Ly6Clow monocyte/macrophage populations. Monocytes/macrophages can be divided into Ly6Chigh
and Ly6Clow populations in steady state spleen (A), retina (B) and retina following EIU induction (C). To validate whether F4/80 can be used to deﬁne inﬂammatory or resident
monocyte/macrophage populations, we repeated the gating strategy using F4/80 instead of NK1.1 to deﬁne the monocyte/macrophage population. F4/80 ﬂuorescence-minus-one
staining (FMO)s were used to deﬁne the F4/80þmonocyte/macrophage population in steady state spleen (D), retina (E) and retina following EIU induction. In each tissue, F4/80 did
not allow discrimination between ‘inﬂammatory’ and ‘resident’ populations, with individual F4/80þ populations having similar Ly6C staining characteristics to corresponding F4/80-
populations; n ¼ 6 animals (pooled eyes); 2 independent experiments.
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proposed by Rose et al., we propose an approach for analyzing
myeloid cell populations in the retina and RPE-choroid in several
commonly used models of ocular inﬂammation. This gating strat-
egy is robust and reproducible, even with the use of different ﬂu-
orophore combinations to those previously reported and provides
cytological conﬁrmation that myeloid cell populations are accu-
rately identiﬁed, including retinal microglia.
Flow cytometry provides a powerful way to analyse cellular
kinetics and dynamics in tissues. This is of particular relevance to
the eye during inﬂammation where it is important to quantify and
proﬁle leukocyte inﬁltration accurately. We demonstrate that this
gating strategy highlights phenotypic differences in myeloid cell
populations across different inﬂammatory models, in laser-induced
CNV in the Ccr2/ deﬁcient mice we demonstrate a signiﬁcant
reduction in numbers of the ‘inﬂammatory’ CD11bþNK1.1ne-
gLy6GnegLy6Chigh population as well as the CD11bþNK1.1ne-
gLy6GnegLy6Clow-neg monocyte/macrophage subset.
The ﬂow cytometry gating strategy validated here will aid in the
evaluation of the kinetics of inﬁltrating myeloid cells and their
functional role in ocular inﬂammation. This strategy utilizes 6
antibody-ﬂuorophore combinations, allowing expansion through
the addition of antibody/cell surface markers for further pheno-
typing of each subset identiﬁed dependent on both the individual
researcher's needs and ﬂow cytometer's capabilities.
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